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Abstract
In genome-wide association studies (GWASs) of common diseases/traits, we often analyze multiple GWASs
with the same phenotype together to discover associated genetic variants with higher power. Since it is difficult
to access data with detailed individual measurements, summary-statistics-based meta-analysis methods have
become popular to jointly analyze data sets from multiple GWASs.
In this paper, we propose a novel summary-statistics-based joint analysis method based on controlling the
joint local false discovery rate (Jlfdr). We prove that our method is the most powerful summary-statistics-
based joint analysis method when controlling the false discovery rate at a certain level. In particular, the Jlfdr-
based method achieves higher power than commonly used meta-analysis methods when analyzing heterogeneous
data sets from multiple GWASs. Simulation experiments demonstrate the superior power of our method over
meta-analysis methods. Also, our method discovers more associations than meta-analysis methods from
empirical data sets of four phenotypes. The R-package is available at: http: // bioinformatics. ust. hk/
Jlfdr. html .
1 Introduction
Understanding genetic mechanisms of common diseases and traits is important in biological and medical
research. The goal of genome-wide association studies (GWASs) is to discover the susceptibility of single
nucleotide polymorphisms (SNPs) to common diseases/traits (Altshuler et al., 2008). Due to decreasing
genotyping costs (Perkel, 2008), constantly emerging successful stories (Klein et al., 2005; Kraft and Haiman,
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2010) and efforts of the GWAS consortiums (Wellcome Trust Case Control Consortium, 2007; Schizophrenia
Working Group of the Psychiatric Genomics Consortium, 2014), more and more GWASs have been conducted
for common phenotypes (Welter et al., 2014).
Analyses of GWAS results show that the identified associations can only explain a small part of the
additive genetic variances. This is referred to as the “missing heritability” problem (Manolio et al., 2009).
The hints of hidden heritability (Gibson, 2010; Yang et al., 2010) and the estimated distribution of common
SNPs’ effect sizes (Park et al., 2010) suggest that common diseases/traits are influenced by thousands of
SNPs with small effects. To discover these genetic variants with small effects, we need to improve studies’
power. Jointly analyzing data sets from multiple GWASs on the same diseases in the same population
provide an opportunity to improve the power.
There are two kinds of joint analysis methods: individual-level joint analysis and summary-statistics-
based joint analysis. Individual-level joint analysis uses individual-level genotype data from all studies.
One such example is mega-analysis (Major Depressive Disorder Working Group of the Psychiatric GWAS
Consortium, 2013), which pools all data together. Summary-statistics-based joint analysis only uses summary
statistics from different studies. Since individual-level genotype data is difficult to access, summary-statistics-
based analysis is widely used in joint analysis. The most commonly used method of summary-statistics-based
joint analysis is meta-analysis (Evangelou and Ioannidis, 2013), which derives a new statistic for each SNP
using summary statistics from multiple studies.
Our focus in this paper is to study summary-statistics-based joint analysis methods. More specifically,
we like to study which joint analysis method provides the highest power for a given false discovery rate level.
Figure 1 illustrates our motivation.
Our major contribution in this paper is that we propose a novel summary-statistics-based joint analysis
method based on controlling the joint local false discovery rate (Jlfdr). The Jlfdr generalizes the concept of
the local false discovery rate (Efron, 2005) from the analysis of single study to the joint analysis of multiple
studies. We prove that our method is the most powerful summary-statistics-based joint analysis method for
a given false discovery rate level. In particular, the Jlfdr-based method is more powerful than commonly
used meta-analysis methods when analyzing heterogeneous data sets from multiple GWASs.
The rest of this paper is organized as follows. In Section 2, we will first give the mathematical formu-
lation of summary-statistics-based joint analysis methods. We will prove that the most powerful summary-
statistics-based joint analysis method should control the Jlfdr. Then we will give implementation details of
the Jlfdr-based method under the Gaussian mixture model. We will also discuss the relationship between the
Jlfdr-based method and meta-analysis methods. In Section 3, we will use simulation experiments to demon-
strate that Jlfdr-based method outperforms meta-analysis methods in terms of achieving higher power. Then
we will show the empirical results using four different data sets. In Section 4, we will discuss limitations of
our current method. Section 5 concludes the paper.
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Figure 1: Rejection boundaries determined by different summary-statistics-based joint analysis
methods: the optimal method and the meta-analysis method. Assume we jointly analyze data from
two GWASs. For simplicity, we assume the tests are one-sided. We plot the test statistic pair (z(1), z(2))
into the coordinate plane. A SNP at the upper right corner shows more significant association than a SNP
at the bottom left corner. The true associated SNPs are plotted with blue circles, and the false associated
SNPs are plotted with yellow triangles. For each rejection boundary, the SNPs in the upper right region are
discovered. All three analysis methods have the same false discovery proportion (10%). The optimal method
has more empirical power (red solid line, 72%) than the meta-analysis method (purple dashed line, 36%).
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2 Method
2.1 Notations and criteria
Our method deals with a multiple GWAS setting. For simplicity, we illustrate the concepts with a two-GWAS
setting. We use parenthesized superscript “(j)” to denote the study index. For example, the sample sizes
in study 1 and 2 are n(1) and n(2), respectively. We use subscript i (i = 1, . . . ,m, m is the total number of
genotyped SNPs) to denote the SNP index.
To detect associations, we construct a null hypothesis for each SNP, in which association is assumed
nonexistent. Assume we use a z-value scheme to detect associations between SNPs and the phenotype, i.e.,
the test statistics follow a standard normal distribution under a null hypothesis. We use µ̂(j) to denote the
observed effect size in study j. The asymptotically standard error of µ̂(j) is σ(j). Correspondingly, the test
statistic in study j is z(j) = µ̂(j)/σ(j). The underlying expected effect size is µ(j). The expected effect size
of the same SNP may vary in different studies due to heterogeneity. The test statistic Z(j) (uppercase letter
indicates a random variable) follows an N(µ(j)/σ(j), 1) distribution. We use z to represent the vector of test
statistics in all studies, i.e., z = (z(1), z(2))T . Similarly, we use µ to represent the vector of expected effect
sizes in all studies, i.e., µ = (µ(1), µ(2))T .
We further assume m0 SNPs have no association with the phenotype and m1 SNPs have associations.
Thus, the null proportion reads pi0 = m0/m (0 ≤ pi0 ≤ 1). We use H0 and H1 to denote the null hypothesis
and the alternative hypothesis, respectively.
In the joint analysis of summary statistics from multiple GWASs, we assume that R of the m hypotheses
are rejected. There are V false positives and S true positives (i.e., V + S = R). Table 1 summarizes the
numbers of hypotheses in the different categories.
Table 1: The status of all hypotheses in the joint analysis. The letter in each cell denotes the count
of the hypotheses in each category.
H0 is true H0 is false Total
H0 is rejected V S R
H0 is not rejected U T m−R
Total m0 m1 m
When testing multiple hypotheses, it is very easy to have false positives by random chance. This problem
is known as the “multiplicity” problem. Many criteria are proposed to address the multiplicity problem. We
present an incomplete list of these criteria in Table 2 (a). Let’s define the false discovery proportion (Fdp)
as V/(R ∨ 1) with “∨” denoting the maximum operation. Fdp is an unknown quantity in real cases. The
classical false discovery rate (FDR) is the expectation of the Fdp. Controlling the FDR is more powerful
than controlling the family-wise error rate (FWER). The Bayesian false discovery rate (Fdr) is the expected
4
value of the Fdp given R > 0. Compared to FDR, Fdr is conditional on R > 0 since we are only interested
in controlling false positives when R > 0. We adopt Fdr in this paper as the criterion to avoid a plethora of
false positives.
Table 2: Different criteria for evaluating a rejection region in multiple testing scenario. Here R is the
rejection region in the analysis. µ denotes effect sizes. V and R as well as other notations are explained in
Table 1. “∨” denotes the maximum operation.
(a) Different criteria for controlling false positives in multiple testing scenario.
Criteria Mathematical Definitions References
Family-wise error rate (FWER) FWER(R) = P (V ≥ 1) Tukey (1953)
False discovery rate (FDR) FDR(R) = E(V/(R ∨ 1)) Benjamini and Hochberg (1995)
Bayesian false discovery rate (Fdr) Fdr(R) = E(V/R∣∣R > 0) Storey (2003)
(b) Different criteria for measuring the amount of true positives in multiple testing scenario.
Criteria Mathematical Definitions References
Power β(R,µ) = P (z ∈ R∣∣H1,µ) Neyman and Pearson (1933)
Bayesian power η(R) = P (z ∈ R∣∣H1) Kruschke (2010)
In addition to controlling false positives, we also need a criterion to measure the amount of true positives
when evaluating a rejection region. A direct concept is power. The classical definition of power is a function
of a given effect size as shown in the first row of Table 2(b). Since effect sizes of associated SNPs are different
and unobserved, the actual power values are unknown. The Bayesian power removes the dependence of power
on effect size by taking the expectation of the empirical power, which is defined as S/m1 (m1 > 0). We list
the definitions of the power and the Bayesian power in Table 2 (b). In this paper, we use the Bayesian power
as the criterion to measure the amount of true positives.
Both Fdr and Bayesian power are functions of the rejection region R. For two different rejection regions
with the same Fdr level, we prefer the region with higher Bayesian power because it can find more true
associations without increasing the proportion of false positives in the findings. Thus, we propose a joint
analysis method determining the optimal rejection region when controlling the Fdr at a certain threshold q,
i.e.
max
R
η(R)
s.t. Fdr(R) ≤ q. (1)
Here η(R) denotes the Bayesian power. Actually, when controlling the Fdr at the same threshold, meta-
analysis methods can also be regarded as the solutions to the above optimization problem with further
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constraint about the form of η(R), i.e.
max
RC
η(RC)
s.t. Fdr(RC) ≤ q
RC = {z
∣∣|g(α,z)| ≥ C}. (2)
Here α = (
√
n(1),
√
n(2))T , and g is a function which has different forms in different meta-analysis methods.
We will give the explicit forms of the function g in meta-analysis methods in subsection 2.4. Also, we will
discuss the relationship between our proposed method and meta-analysis methods in detail in that subsection.
In the next subsection, we will present the solution to the optimization problem in Eq. (1).
2.2 Jlfdr and optimal rejection region
To derive the solution to the optimization problem in Eq. (1), we need to introduce the concept of joint local
false discovery rate (Jlfdr) first. Jlfdr is a simple extension of the local false discovery rate (Efron, 2005)
from the analysis of single study to the joint analysis of multiple studies. It reads as
Jlfdr(z) = P (H0
∣∣z), (3)
which is the posterior probability of a null hypothesis, given the observed summary statistic vector z.
The relationship between Jlfdr and Fdr is (see the Supplementary Note for details)
Fdr(R) = E(Jlfdr(z)∣∣z ∈ R). (4)
In other words, Fdr is the expectation of Jlfdr, given that the test statistic vector is in the rejection region
R.
Let us define a rejection region RO = {z
∣∣Jlfdr(z) ≤ t(q)}, where t(q) is a threshold such that Fdr(RO) =
q. We have the following theorem:
Theorem 1. For any rejection region R with Fdr(R) ≤ q, we have η(R) ≤ η(RO).
We show the proof of Theorem 1 in the Supplementary Note. Theorem 1 shows that RO is the most
powerful rejection region when controlling Fdr at q. This gives us a clue that we can improve the power of
summary-statistics-based joint analysis by controlling the Jlfdr. In the next section, we shall provide details
of the implementation of the Jlfdr-based method under the Gaussian mixture model.
2.3 Implementation of Jlfdr-based method under the Gaussian mixture model
The hints of hidden heritability (Gibson, 2010; Yang et al., 2010) and the estimated distribution of common
SNPs’ effect sizes (Park et al., 2010) suggest that thousands of common SNPs with small effect sizes are
associated with complex diseases. A natural prior to depict this “infinitesimal model” (Gibson, 2012) is
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Gaussian distribution with mean 0 and variance σ20 . We assume the effect sizes of associated SNPs have this
prior distribution. Since we don’t know which SNP is associated with diseases, we propose the following
two-component mixture model to describe the prior distribution of effect sizes:
µ ∼ pi0δ0 + (1− pi0)N(0, σ20), (5)
where δ0 is the unit point mass distribution at zero.
There may be some heterogeneity in different studies. The effect sizes of the same SNP may vary in
different studies. We assume the effect sizes of the same associated SNP in different studies are normally
distributed with mean µ and variance τσ20 , i.e., µ
(j)
∣∣H1 ∼ N(µ, τσ20). The distribution of the effect size
vector µ = (µ(1), µ(2))T is
µ ∼ pi0δ0 + (1− pi0)N2
0,
 (τ + 1)σ20 σ20
σ20 (τ + 1)σ
2
0
 , (6)
where δ0 is the bivariate unit point mass distribution at the origin, and N2(η,Σ) denotes the bivariate
Gaussian distribution with expectation η and covariance matrix Σ.
Since the observed effect size µ̂(j) asymptotically follows Gaussian distribution N(µ(j), (σ(j))2), the test
statistics vector Z i = (Z
(1)
i , Z
(2)
i )
T with prior (6) follows two-component Gaussian mixture distribution:
Z i ∼ pi0N2(0, I) + (1− pi0)N2(0, I + Σi), where Σi =
 (τ + 1)( σ0σ(1)i )2 σ
2
0
σ
(1)
i σ
(2)
i
σ20
σ
(1)
i σ
(2)
i
(τ + 1)( σ0
σ
(2)
i
)2
 . (7)
Here, I is the identity matrix.
In order to obtain the global behavior of all SNPs, we need to obtain the marginal distribution of the
test statistic vectors of all SNPs. Overall, the test statistic vector Z follows
Z ∼ pi0N2(0, I) + 1− pi0
m1
∑
i∈S1
N2(0, I + Σi). (8)
Here S1 is the index set of all associated SNPs, and m1 is the corresponding cardinality of S1. S1 is normally
unknown.
The above Gaussian mixture model is computationally difficult due to the large number of components
(m1 is normally in the range of hundred to thousand). To simplify the model, we use a K-component
Gaussian mixture model to approximate the non-null components, i.e.,
1− pi0
m
m∑
i=1
N2(0, I + Σi) ≈
K∑
k=1
pi1kN2(0, I + Σ¯k), where
K∑
k=1
pi1k = 1− pi0. (9)
Then we reduce the distribution of Z to a (K + 1)-component Gaussian mixture model:
Z ∼ pi0N2(0, I) +
K∑
k=1
pi1kN2(0, I + Σ¯k). (10)
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There are some unknown parameters pi1 = (pi11, . . . , pi1K)
T and Σ¯ = {Σ¯1, . . . , Σ¯K} in the above mixture
model. Dempster et al. (1977) proposed an EM-algorithm to estimate parameters with unobserved latent
variables. With the observed vectors of summary statistics z i (i = 1, . . . ,m), we use the EM-algorithm
to estimate the parameters pi1 and Σ¯ in the Gaussian mixture model (10). Please note that pi0 is always
much larger than any entry of pi1 in the GWAS setting. Hence, a Dirichlet(β0,0
T ) prior is added for the
proportions (pi0,pi1
T ). This is the same penalty strategy proposed by Muralidharan (2010). Our experiments
show that the rejection regions are not sensitive to the penalization parameter β0 and the number of mixture
components in the associated SNPs K. In our default setting, β0 = m/5 and K = 2.
Denote the probability density function (pdf) of bivariate normal distribution N2(0, I) as f0(x1, x2) and
the pdf of N2(0, I + Σ¯k) as f1(x1, x2|Σ¯k). The Jlfdr reads
Jlfdr(z) =
pi0f0(z1, z2)
pi0f0(z1, z2) +
∑K
k=1 pi1kf1(z1, z2|Σ¯k)
. (11)
After calculating the Jlfdr, we approximate Fdr as
Fdr(R) = E(Jlfdr(z)∣∣z ∈ R) ≈ 1|{z ∈ R}|∑
z∈R
Jlfdr(z). (12)
We determine the optimal rejection region RO by Jlfdr-thresholding, which determines the rejection
region with Jlfdr(z) smaller than the threshold t(q). To determine the threshold t(q), we sort the calcu-
lated Jlfdr values of each SNP in an ascending order first. Denote the a-th Jlfdr value as Jlfdra. We can
approximate the Fdr of the region Ra = {z
∣∣Jlfdr(z) ≤ Jlfdra} as
Fdr(Ra) ≈ 1
a
a∑
b=1
Jlfdrb. (13)
We use c to denote the largest a such that Fdr(Ra) ≤ q, namely
c = max{a∣∣Fdr(Ra) ≤ q}. (14)
Then the Jlfdr threshold t(q) is Jlfdrc. We reject all SNPs with Jlfdr(z) ≤ t(q).
We present the detailed steps of the Jlfdr-based method in Algorithm 1.
2.4 Relationship between Jlfdr-based method and meta-analysis methods
We have the following theorem about the rejection region of Jlfdr-based method when using the Gaussian
mixture model:
Theorem 2. In the Gaussian mixture model (8), the rejection region of the Jlfdr-based method is
R1 = {z
∣∣ ∑
i∈S1
exp(zT (I − (I + Σi)−1)z) ≥ C1}, (15)
where C1 is a constant determined by Fdr(RO1) = q. If no heterogeneity exists between studies, the rejection
region is
R2 = {z
∣∣|αTz | ≥ C2}, (16)
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Algorithm 1 Jlfdr-based method for summary-statistics-based joint analysis
Inference using the EM-algorithm:
Initialize pi1 and Σ¯
repeat
E Step:
pit0 ← 1−
K∑
k=1
pit1k
hi0 ← pi
t
0f0(z
(1)
i , z
(2)
i )
pit0f0(z
(1)
i , z
(2)
i ) +
∑K
k=1 pi1kf1(z
(1)
i , z
(2)
i |Σt1k)
, i = 1, · · · ,m
hil ← pi
t
1lf1(z
(1)
i , z
(2)
i |Σt1l)
pit0f0(z
(1)
i , z
(2)
i ) +
∑K
k=1 pi1kf1(z
(1)
i , z
(2)
i |Σt1k)
, l = 1, · · · ,K
M Step:
pit+11l ←
∑m
i=1 hil
m+ β0
Σt+11l ←
∑m
i=1 hilz iz
T
i∑m
i=1 hil
− I, l = 1, · · · ,K
until pi1 and Σ¯ converge
Jlfdr-thresholding:
Initialize t(q)← 0
Calculate Jlfdr for each SNP using Eq. (11) with inferred pi1 and Σ¯.
Sort calculated Jlfdr in ascending order
for a← 1 to m do
Calculate Fdr(Ra) using Eq. (13).
if Fdr(Ra) > q, then
t(q)← Jlfdra−1; break
Output: the SNPs with Jlfdr ≤ t(q)
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where α = (
√
n(1),
√
n(2))T , and C2 is a constant determined by Fdr(RO2) = q.
We present the proof of the above theorem in the Supplementary Note.
Meta-analysis methods are the most commonly used summary-statistics-based joint analysis methods.
In meta-analysis, we usually calculate the weighted average of effect sizes in different studies. Dividing the
weighted average effect size by its standard error yields a new z-value-based test statistic. There are two
kinds of models in the meta-analysis: fixed-effects model and random-effects model.
In the fixed-effects model, we assume that the underlying true effect sizes in different studies are identical.
This corresponds to τ = 0 in the Gaussian mixture model 8. The optimal weighting strategy is the inverse-
variance weighting since it minimizes the variance of the weighted average. Each effect size is weighted by
the inverse of its variance, i.e.,
µ̂w =
w1µ̂
(1) + w2µ̂
(2)
w1 + w2
, with wj =
1
(σ(j))2
, j = 1, 2. (17)
Here µ̂w is the weighted average effect size. Its standard error is
σw =
√
1
w1 + w2
. (18)
Dividing µ̂w by σw yields the new test statistic zw. We have the following theorem about the rejection region
of the fixed-effects meta-analysis method (See the Supplementary Note for detailed proof):
Theorem 3. The rejection region of the fixed-effects meta-analysis method is asymptotically
R3 = {z
∣∣|αTz | ≥ C3}, (19)
where α = (
√
n(1),
√
n(2))T , and C3 is a constant determined by Fdr(R3) = q. .
This kind of rejection region is illustrated in Figure 1. The region coincides with the rejection region
of the Jlfdr-based method when no heterogeneity exists between studies. Hence, the Jlfdr-based method
and the fixed-effects meta-analysis method will have the same performance. In contrast, if heterogeneity
exists between studies, the rejection regions determined by the Jlfdr-based method and the fixed-effects
meta-analysis method are different. According to Theorem 1, the rejection region determined by the Jlfdr-
based method can achieve the highest power among all summary-statistics-based joint analysis methods
when controlling the Fdr. In other words, the Jlfdr-based method is more powerful than the fixed-effects
meta-analysis method.
In the random-effects model, we assume that the true effect sizes in different studies are not identical
and follow a distribution. Then we adjust the weights by incorporating the between-study variance. The
weighted average effect size is
µ̂∗w =
w∗1µ̂
(1) + w∗2µ̂
(2)
w∗1 + w
∗
2
,
with w∗j =
1
(σ(j))2 + ∆ˆ2
, j = 1, 2, and ∆ˆ2 = max
(
0,
w1(µ̂
(1) − µ̂w)2 + w2(µ̂(2) − µ̂w)2 − 1
(w1 + w2)− (w21 + w22)/(w1 + w2)
)
. (20)
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Its standard error is
σ∗w =
√
1
w∗1 + w
∗
2
. (21)
Dividing µ̂∗w by σ
∗
w yields the new test statistic z
∗
w. We have the following theorem about the rejection region
of the random-effects meta-analysis method (See the Supplementary Note for detailed proof):
Theorem 4. The rejection region of the random-effects meta-analysis method is asymptotically
R4 = {z
∣∣ ∣∣∣∣αTV zαTVα
∣∣∣∣ ≥ C4}
with V =
 1/(1 + α21s) 0
0 1/(1 + α22s)
 and s = max(0, ||α||22 [||z ||22 − (αTz/||α||2)2 − 1]
(αTα)2 − ||αo2||22
)
. (22)
Here α = (
√
n(1),
√
n(2))T , αo2 = (n(1), n(2))T which is the 2nd Hadamard power of α, and C4 is a constant
determined by Fdr(R4) = q.
If no heterogeneity exists between studies, the random-effects meta-analysis method is less powerful than
the fixed-effects meta-analysis method and the Jlfdr-based method. If heterogeneity exists between studies,
we usually need a large number of studies to estimate the between-study variance precisely in the random-
effects meta-analysis. Since we usually only have a few GWASs of the same diseases in the same population,
the random-effects meta-analysis is not powerful enough. The Jlfdr-based method overcomes this problem
by borrowing information from all genotyped SNPs. In any case, the rejection region determined by the
Jlfdr-based method and the random-effects meta-analysis method are different. According to Theorem 1,
the Jlfdr-based method is more powerful than the random-effects meta-analysis method.
3 Results
3.1 Simulation experiments
We use simulation experiments to demonstrate that the Jlfdr-based method is more powerful than the
commonly used meta-analysis methods in analyzing summary statistics from multiple GWASs.
In our simulation experiments, we fix the sample size at 10000 in study 1. We conduct experiments with
different sample sizes of 5000, 10000 and 15000 in study 2. The sample size ratios n(2)/n(1) are 0.5, 1 and 1.5
correspondingly. The individual numbers in the control group and case group are the same in both studies,
and the number of SNPs is m = 1× 106. We simulate the minor allele frequency of each SNP according to
uniform distribution U(0.05, 0.5). The proportion of the associated SNPs is 5%. For associated SNPs, the
expected log-odds ratio µ(j) in each study is simulated according to the following model:
µ(j)
∣∣H1 ∼ N(µ, τσ20)
µ
∣∣H1 ∼ N(0, σ20), (23)
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where σ20 = 0.04. In the homogeneous setting, τ = 0. In the heterogeneous setting, τ = 0.5. For non-
associated SNPs, the expected log-odds ratio µ(j) is 0. The prevalence of the disease is 1%. We use the
log-odds ratio test to detect associations in our experiments.
We use the Jlfdr-based method, the fixed-effects meta-analysis method and the random-effects meta-
analysis method to jointly analyze summary statistics from study 1 and study 2. The Fdr is controlled
at q = 5 × 10−5. In the fixed-effects meta-analysis and the random-effects meta-analysis, we use the one-
dimensional mixture method Muralidharan (2010) to control the Fdr at q.
In the homogeneous setting (τ = 0), each SNP shares the same expected effect size between the two
studies. Figure 2 presents the average empirical power and the average Fdp of 10 experimental runs using
different methods. The average Fdp is well controlled in all methods. In this setting, the average empirical
powers are almost the same in the Jlfdr-based method and the fixed-effects meta-analysis method. The
subtle differences are due to random initial choices of the EM-algorithm and the Fdr approximations used
in Eq. (13). This verifies the previous statement about the equivalence between the Jlfdr-based method and
the fixed-effects meta-analysis method in the homogeneous setting.
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Figure 2: (a) The average empirical power and (b) the average Fdp in the homogeneous setting
(τ = 0) of the simulation experiment. The experiments are repeated 10 times with different sample size
ratios (n(2)/n(1) = 0.5, 1 and 1.5). The average Fdp of the three methods (the Jlfdr-based method (Jlfdr),
the fixed-effects meta-analysis method (MetaF) and the random-effects meta-analysis method (MetaR)) are
about 5× 10−5. When controlling Fdr at the same level, the Jlfdr-based method and the fixed-effects meta-
analysis method have almost the same average empirical power. The subtle differences are due to random
initial choices of the EM-algorithm and the Fdr approximations used in Eq. (13).
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In the heterogeneous setting (τ = 0.5), the expected effect sizes of each SNP vary between studies. Figure
3 plots the discovered associations using the Jlfdr-based method and the fixed-effects meta-analysis method
in one run when n(2) = 10000. Although the Jlfdr-based method missed some associations detected by the
fixed-effects meta-analysis method, it identifies more associations than the meta-analysis method. We ran
the simulation experiments 10 times for the sample size ratio n(2)/n(1) = 0.5, 1 and 1.5. Figure 4 shows
the average empirical power and the average Fdp. The average Fdp using all three methods are about
q = 5× 10−5 in all sample size ratio settings. From the figure, we can see that the Jlfdr-based method can
achieve higher power than the other methods when controlling Fdr at the same threshold.
3.2 Real data applications
3.2.1 SCZ data from PGC
We jointly analyze the summary statistics from schizophrenia (SCZ) studies conducted by the Psychiatric
Genomics Consortium (PGC). The summary statistics from two SCZ studies, Sweden+SCZ1 (Ripke et al.,
2013) and SCZ2 (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014), are avail-
able from the PGC. Sweden+SCZ1 is a large-scale meta-analysis of Swedish and mixed-European ancestry
individuals that comprises 13,833 schizophrenia cases and 18,310 controls in the analysis. We use it as Study
1. SCZ2 is a larger-scale meta-analysis that comprises 36,989 schizophrenia cases and 113,075 controls. The
analysis includes the individuals which have been analyzed in Sweden+SCZ1. By using the following inverse
meta-analysis formula, we obtain the summary statistics from the meta-analysis comprising the individuals
only be analyzed in SCZ2. The formula is
z(2) =
zw/σw − z(1)/σ(1)
1/(σw)2 − 1/(σ(1))2 . (24)
We use z(2) as the summary statistics of Study 2. We remove the SNPs with p-value< 0.01 in the test of
homogeneity. After that, there are m = 8, 157, 410 SNPs remaining.
We use the Jlfdr-based method, the fixed-effects meta-analysis method and the random-effects meta-
analysis method to jointly analyze the summary statistics from two studies. The Fdr is controlled at q =
5× 10−5. We adopt the one-dimensional mixture method to control the Fdr at q in meta-analysis methods.
Figure 5(a) plots the discovered associations using the Jlfdr-based method and the fixed-effects meta-
analysis method. The Jlfdr-based method identifies more associations. Table 3 shows the numbers of
discovered associations and the rejection criteria of the different analysis methods. Besides the loci discovered
by meta-analysis methods, there are eight novel loci discovered by the Jlfdr-based method. Each locus is
separated by at least 500 kilobases (kb) or a weak linkage disequilibrium (r2 < 0.1). The SNPs showing the
most significant association with SCZ in these novel loci are presented in Supplementary Table 1.
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Figure 3: The discovered ssociations in the heterogeneous setting (τ = 0.5) of the simulation
experiment. Both the first and second studies have 10000 individuals. For each SNP, the pair of summary
statistics (z(1), z(2)) is plotted with transformation (|z(1)|, sgn(z(1))z(2)). We use light grey circles to represent
the associations discovered by both the Jlfdr-based method and fixed-effects meta-analysis method. We use
black upward-pointing triangles and dark grey downward-pointing triangles to represent the associations
only discovered by the Jlfdr-based method and the fixed-effects meta-analysis method, respectively. The
rejection boundary in the Jlfdr-based method is plotted as the solid curve. The rejection boundary in the
fixed-effects meta-analysis method is plotted as the dashed straight line. The Jlfdr-based method discovered
more associations overall than the meta-analysis method, although it also misses some associations identified
by the meta-analysis method.
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Figure 4: (a) The average empirical power and (b) the average Fdp in the heterogeneous setting
(τ = 0.5) of the simulation experiment. We ran experiments 20 times with different sample size ratios
(n(2)/n(1) = 0.5, 1 and 1.5). The average Fdp values in three methods are about 5×10−5. When controlling
Fdr at the same level, our proposed Jlfdr-based method can achieve higher power than the other methods
in every sample size ratio setting.
Table 3: The rejection criterion and the number of identified associations in SCZ data from
the PGC. zMF and zMR are the combined z-values in the fixed-effects meta-analysis and random-effects
meta-analysis, respectively.
Method Rejection Criterion #{Identified SNPs}
Jlfdr-based method Jlfdr(z) ≤ 3.206× 10−4 13405
Fixed-effects meta-analysis |zMF | ≥ 5.273 13014
Random-effects meta-analysis |zMR| ≥ 5.352 8348
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Figure 5: The rejection region determined in the empirical datasets: (a) SCZ data from the
PGC; (b) SLE data from dbGaP; (c) BMI data from the GIANT; (d) WHRadjBMI data from the GIANT.
The descriptions of the three datasets are presented in the main text. For each SNP, the vector of summary
statistics (z(1), z(2)) is plotted with transformation (|z(1)|, sgn(z(1))z(2)). We use light grey circles to represent
the associations discovered by both the Jlfdr-based method and the fixed-effects meta-analysis method. We
use black upward-pointing triangles and dark grey downward-pointing triangles to represent the associations
only discovered by the Jlfdr-based method and the fixed-effects meta-analysis method, respectively.16
3.2.2 SLE data from dbGaP
We conduct summary-statistics-based joint analysis in systemic lupus erythematosus (SLE) data from
phs000122.v1.p1 and phs000216.v1.p1 in dbGaP (Mailman et al., 2007; Tryka et al., 2014). We use the
study phs000122.v1.p1, in which there are 1,311 SLE cases and 3,340 controls, as Study 1, and we use the
study phs000216.v1.p1, in which there are 706 cases and 353 controls, as Study 2. The individuals in the
first study are all North Americans of European descent, and those in the second study are all females of
European ancestry. We use the following quality control procedures for both studies:
1. Missing data control: The SNPs with a missing data rate larger than 1% are discarded.
2. Minor allele frequency control: The SNPs with minor allele frequency less than 0.05 in either case
group or control group are discarded.
3. Hardy-Weinberg equilibrium control: In the Hardy-Weinberg equilibrium test, the SNPs with p-values
less than 0.001 in either case group or control group are discarded.
4. Homogeneity control: In the homogeneity test, SNPs with p-values less than 0.01 are discarded.
After the quality control steps, there are m = 195, 318 autosome SNPs remaining.
We use q = 5 × 10−5 as the Fdr threshold in all analyses. 5(b) plots the associations discovered by
the Jlfdr-based method and the fixed-effects meta-analysis method. The Jlfdr-based method discovers more
associations than the meta-analysis methods. Table 4 lists the numbers of the associations discovered using
the different methods. Besides the loci discovered by meta-analysis methods, there are three novel loci dis-
covered by the Jlfdr-based method. The loci are separated by at least 500kb or a weak linkage disequilibrium
(r2 < 0.1). The most significant associations in these novel loci can be seen in Supplementary Table 2.
Table 4: The rejection criterion and the number of identified associations in SLE data from
dbGaP. zMF and zMR are the combined z-values in the fixed-effects meta-analysis and random-effects
meta-analysis, respectively.
Method Rejection Criterion #{Identified SNPs}
Jlfdr-based method Jlfdr(z) ≤ 5.543× 10−4 106
Fixed-effects meta-analysis |zMF | ≥ 5.508 94
Random-effects meta-analysis |zMR| ≥ 5.586 54
3.2.3 BMI data from GIANT
We jointly analyze summary statistics from body mass index (BMI) studies conducted by the Genetic
Investigation of ANthropometric Traits (GIANT) consortium (Locke et al., 2015). We use the joint GWAS
and metabochip meta-analysis of 152,893 European men as Study 1, and we use the joint GWAS and
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metabochip meta-analysis of 171,977 European women as Study 2. There are m = 2, 466, 338 autosome
SNPs passing the homogeneity control (p-value≥ 0.01).
We use q = 5 × 10−5 as the Fdr threshold in all analyses. Figure 5(c) plots the associations discovered
by the Jlfdr-based method and the fixed-effects meta-analysis method. The Jlfdr-based method discovers
more associations than meta-analysis methods. Table 5 shows the number of discovered associations and
the corresponding rejection criterion of each method. There are six novel loci discovered by the Jlfdr-based
method. The SNPs showing the most significant associations in these novel loci are listed in Supplementary
Table 3.
Table 5: The rejection criterion and the number of identified associations in BMI data from
the GIANT. zMF and zMR are the combined z-values in the fixed-effects meta-analysis and random-effects
meta-analysis, respectively.
Method Rejection Criterion #{Identified SNPs}
Jlfdr-based method Jlfdr(z) ≤ 3.722× 10−4 2717
Fixed-effects meta-analysis |zMF | ≥ 5.336 2667
Random-effects meta-analysis |zMR| ≥ 5.383 2186
3.2.4 WHRadjBMI data from GIANT
We conduct joint analysis in waist-to-hip ratio after adjusting for BMI (WHRadjBMI) studies from GIANT
consortium (Shungin et al., 2015). We use the joint GWAS and metabochip meta-analysis of 93,480 European
men as Study 1, and we use the joint GWAS and metabochip meta-analysis of 116,742 European women as
Study 2. There are m = 2, 127, 324 autosome SNPs passing the homogeneity control (p-value≥ 0.01).
Figure 5(d) highlights the associations discovered by the Jlfdr-based method and the fixed-effects meta-
analysis method. The Jlfdr-based method identifies more associations than meta-analysis methods when
controlling Fdr at the same level q = 5× 10−5. Table 6 shows the number of the discovered associations and
the corresponding rejection criterion of each method. Besides the loci discovered by meta-analysis methods,
there are four novel loci discovered by the Jlfdr-based method. The details of the most significant SNPs in
these loci are listed in Supplementary Table 4.
4 Discussion
Both the Jlfdr-based method and the meta-analysis methods jointly analyze summary statistics from multiple
GWASs. Meta-analysis methods collapse the test statistics of all studies into a weighted average value for
each SNP, which is simpler than the Jlfdr-based method. When no heterogeneity exists between studies,
the Jlfdr-based method will degenerate to the fixed-effects meta-analysis method. This can be understood
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Table 6: The rejection criterion and the number of identified associations in WHRadjBMI
data from the GIANT. zMF and zMR are the combined z-values in the fixed-effects meta-analysis and
random-effects meta-analysis, respectively.
Method Rejection Criterion #{Identified SNPs}
Jlfdr-based method Jlfdr(z) ≤ 5.750× 10−4 452
Fixed-effects meta-analysis |zMF | ≥ 5.617 420
Random-effects meta-analysis |zMR| ≥ 5.742 192
by the fact that there is no information loss during the collapsing when all studies are homogeneous. When
heterogeneity exists between studies, however, the Jlfdr-based method can achieve higher power than the
fixed-effects meta-analysis method. This is understandable as information about heterogeneity is lost during
collapse when using the meta-analysis method. Since heterogeneity widely exists in most cases, we suggest
to use the Jlfdr-based method instead of meta-analysis methods to jointly analyze summary statistics from
multiple GWASs.
This paper proves that the Jlfdr-based method is the most powerful summary-statistics-based joint anal-
ysis method when the underlying distribution of the test statistics is known. In reality, we only know the
theoretical distribution under a null hypothesis. The distribution under alternative hypotheses is usually
unknown. Hence, in the implementation of the Jlfdr-based method, we assume test statistics follow the
Gaussian mixture model. Then we use the EM-algorithm to infer parameters in the mixture model. Viola-
tion of the model assumptions and inaccuracy of parameters estimation will decrease the performance of the
Jlfdr-based method.
We assume an independence between SNPs in the Gaussian mixture model. However, correlations be-
tween nearby SNPs often exist, which is known as linkage disequilibrium. We may further improve the
Jlfdr-based method by taking advantage of the dependency information between SNPs.
5 Conclusion
Jointly analyzing data sets from multiple GWASs is a common strategy to discover associations. Since it
is usually difficult to access individual-level genotyping data, summary-statistics-based joint analysis has
become popular for jointly analyzing data sets from multiple GWASs. Among different summary-statistics-
based joint analysis methods, we prefer the method with higher Bayesian power when Fdr is controlled at
the same level, because it can discover more associations. With this criterion, we propose the Jlfdr-based
method. It is the most powerful summary-statistics-based method. Simulation and empirical experiments
demonstrate its superior performance over traditional meta-analysis methods.
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